McNeilJJWolfeRWoodsRLet al.
Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med2018;
379: 1509–1518.
2.
McNeilJJWoodsRLNelsonMRet al. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med2018;
379: 1499–1508.
3.
RidkerPM.Should aspirin be used for primary prevention in the post-statin era?N Engl J Med2018;
379: 1572–1574.
4.
CookNRLeeIMGazianoJMet al.
Low-dose aspirin in the primary prevention of cancer. The Women’s Health Study: a randomized controlled trial. JAMA2005;
294: 47–55.
5.
GrazianoJMBrotonsCCoppolecchiaRet al.
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet2018;
392: 1036–1046.
6.
Bibbins-DomingoK;
U.S. Preventive Services Task Force. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer. Ann Intern Med2016;
164: 836–845.
7.
ZhaoMWhitcombBWPurdue-SmitheACet al.
Physical activity is not related to risk of early menopause in a large prospective study. Hum Reprod2018;
33: 1960–1967.
8.
The ESHRE Guideline Group on POI.
ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod2016;
31: 926–937.
9.
The Premenopausal Breast Cancer Collaborative Group.
Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncol2018; doi:10.1001/jamaoncol.2018.1771.
